Physical and transcript map of the minimally deleted region III on 17p implicated in the early development of Barrett's oesophageal adenocarcinomaDUNN, Julie R; RISK, Janet M; LANGAN, Joanne E et al.Oncogene (Basingstoke). 2003, Vol 22, Num 26, pp 4134-4142, issn 0950-9232, 9 p.Article

Tissue polypeptide antigen (TPA) in comparison with mutations of tumour suppressor gene p53 (TP53) in patients with bladder cancerECKE, Thorsten H; LENK, Severin V; SCHLECHTE, Horst H et al.Anticancer research. 2003, Vol 23, Num 2A, pp 957-962, issn 0250-7005, 6 p.Conference Paper

Gene Therapy Progress and Prospects: cancer gene therapy using tumour suppressor genesMCNEISH, I. A; BELL, S. J; LEMOINE, N. R et al.Gene therapy (Basingstoke). 2004, Vol 11, Num 6, pp 497-503, issn 0969-7128, 7 p.Article

Alteration of the PATCHED locus in superficial bladder cancerABOULKASSIM, Tahar O; LARUE, Hélène; LEMIEUX, Patricia et al.Oncogene (Basingstoke). 2003, Vol 22, Num 19, pp 2967-2971, issn 0950-9232, 5 p.Article

Data mining the p53 pathway in the Fugu genome: evidence for strong conservation of the apoptotic pathwayLE BRAS, Morgane; BENSAAD, Karim; SOUSSI, Thierry et al.Oncogene (Basingstoke). 2003, Vol 22, Num 32, pp 5082-5090, issn 0950-9232, 9 p.Article

Expression of the proliferating cell nuclear antigen and protein products of tumour suppressor genes in the human foetal testisMARIC, S; BULIC-JAKUS, F; JEZEK, D et al.Andrologia. 2004, Vol 36, Num 1, pp 24-30, issn 0303-4569, 7 p.Article

p53 alterations in human cancer : more questions than answersSOUSSI, T.Oncogene (Basingstoke). 2007, Vol 26, Num 15, pp 2145-2156, issn 0950-9232, 12 p.Article

CLCA2 tumour suppressor gene in 1p31 is epigenetically regulated in breast cancerXIURONG LI; COWELL, John K; SOSSEY-ALAOUI, Khalid et al.Oncogene (Basingstoke). 2004, Vol 23, Num 7, pp 1474-1480, issn 0950-9232, 7 p.Article

Loss of Smad4 correlates with loss of the invasion suppressor E-cadherin in advanced colorectal carcinomasREINACHER-SCHICK, Anke; BALDUS, Stephan E; ROMDHANA, Bashra et al.Journal of pathology. 2004, Vol 202, Num 4, pp 412-420, issn 0022-3417, 9 p.Article

Haplo-insufficiency: a driving force in cancerBERGER, Alice H; PANDOLFI, Pier Paolo.Journal of pathology (Print). 2011, Vol 223, Num 2, pp 137-146, issn 0022-3417, 10 p.Article

Loss of CDKN2A and p14^ARF expression occurs frequently in human nonmelanoma skin cancersPACIFICO, A; GOLDBERG, L. H; PERIS, K et al.British journal of dermatology (1951). 2008, Vol 158, Num 2, pp 291-297, issn 0007-0963, 7 p.Article

Progression of myelodysplastic syndrome: allelic loss on chromosomal arm 1pMORI, Naoki; MOROSETTI, Roberta; MIZOGUCHI, Hideaki et al.British journal of haematology. 2003, Vol 122, Num 2, pp 226-230, issn 0007-1048, 5 p.Article

DNA methylation and allelic losses on chromosome arm 14q in oligodendroglial tumoursFELSBERG, J; YAN, P. S; HUANG, T. H.-M et al.Neuropathology and applied neurobiology (Print). 2006, Vol 32, Num 5, pp 517-524, issn 0305-1846, 8 p.Article

Downregulation of DBC1 expression in acute lymphoblastic leukaemia is mediated by aberrant methylation of its promoterJOSE-ENERIZ, Edurne San; AGIRRE, Xabier; PROSPER, Felipe et al.British journal of haematology. 2006, Vol 134, Num 2, pp 137-144, issn 0007-1048, 8 p.Article

WWOX mRNA expression profile in epithelial ovarian cancer supports the role of WWOX variant 1 as a tumour suppressor, although the role of variant 4 remains unclearGOURLEY, C; PAIGE, A. J. W; TAYLOR, K. J et al.International journal of oncology. 2005, Vol 26, Num 6, pp 1681-1689, issn 1019-6439, 9 p.Article

PTEN/MMACI expression in melanoma resection specimensDEICHMANN, M; THOME, M; BENNER, A et al.British journal of cancer. 2002, Vol 87, Num 12, pp 1431-1436, issn 0007-0920, 6 p.Article

Investigation into FOXE1 genetic variations in cutaneous squamous cell carcinomaVENZA, I; VISALLI, M; TRIPODO, B et al.British journal of dermatology (1951). 2010, Vol 162, Num 3, pp 681-683, issn 0007-0963, 3 p.Article

Frequent epigenetic inactivation of cystatin M in breast carcinomaSCHAGDARSURENGIN, U; PFEIFER, G. P; DAMMANN, R et al.Oncogene (Basingstoke). 2007, Vol 26, Num 21, pp 3089-3094, issn 0950-9232, 6 p.Article

Aberrant methylation of the Wnt antagonist SFRP1 in breast cancer is associated with unfavourable prognosisVEECK, J; NIEDERACHER, D; HUSZKA, C et al.Oncogene (Basingstoke). 2006, Vol 25, Num 24, pp 3479-3488, issn 0950-9232, 10 p.Article

Fibulin I is downregulated through promoter hypermethylation in gastric cancerCHENG, Y. Y; JIN, H; LIU, X et al.British journal of cancer. 2008, Vol 99, Num 12, pp 2083-2087, issn 0007-0920, 5 p.Article

The elusive multiple self-healing squamous epithelioma (MSSE) gene : further mapping, analysis of candidates, and loss of heterozygosityBOSE, S; MORGAN, L. J; BOOTH, D. R et al.Oncogene (Basingstoke). 2006, Vol 25, Num 5, pp 806-812, issn 0950-9232, 7 p.Article

Hypermethylation of gene promoters in hematological neoplasiaCHIM, C. S; LIANG, R; KWONG, Y. L et al.Hematological oncology. 2002, Vol 20, Num 4, pp 167-176, issn 0278-0232, 10 p.Article

Dominant negative mutations in the Wilms tumour (WT1) gene cause Denys-Drash syndrome: proof that a tumour-suppressor gene plays a crucial role in normal genitourinary developmentHASTIE, N. D.Human molecular genetics (Print). 1992, Vol 1, Num 5, pp 293-295, issn 0964-6906Article

Immunohistochemical detection ofthe p53 oncoprotein in tumours of melanocytic originYAMAMOTO, M; TAKAHASHI, H.Virchows Archiv. A, Pathological anatomy and histopathology. 1993, Vol 422, Num 2, pp 127-132, issn 0174-7398Article

The role of caveolin-1 in human breast cancerPATANI, Neill; MARTIN, Lesley-Ann; REIS-FILHO, Jorge S et al.Breast cancer research and treatment. 2012, Vol 131, Num 1, pp 1-15, issn 0167-6806, 15 p.Article